Lombardi Comprehensive Cancer Center, Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
Lombardi Comprehensive Cancer Center, Georgetown University has participated in 15 clinical trials with 7 currently active.
Therapeutic areas: Colorectal Neoplasms, Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance.
Sponsors: Dynavax Technologies Corporation, Georgetown University, Hackensack Meridian Health.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in District of Columbia · View every site in Washington D.C.
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lombardi Comprehensive Cancer Center, Georgetown University has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Comprehensive Cancer Center, Georgetown University has 15 clinical trials on record, with 7 currently active. Their work covers Colorectal Neoplasms, Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance.
Lombardi Comprehensive Cancer Center, Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.